Exchange: NASDAQ·Updated 07:22 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 03

Estimated EPS

-$0.29

Reported EPS

-$0.38

Surprise

-32.56%

Estimated Rev

$12.73M

Reported Rev

$10.88M

Surprise

-14.55%

• Reported GAAP EPS of -$0.38 down -80.95% YoY • Reported revenue of $10.88M up 18.07% YoY • ClearPoint Neuro estimates total revenue in 2026 to be between $48.0 million and $52.0 million as the company prioritizes investments in clinical case support and global regulatory product expansion initiatives.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.31
--
--
N/A
Q2 '26
-$0.29
-$0.38
-32.56%
MISSED
Q1 '26
-$0.27
-$0.32
-17.07%
MISSED
Q4 '25
-$0.20
-$0.26
-30.00%
MISSED
Q3 '25
-$0.21
-$0.21
--
EXPECTED

Advertisement|Remove ads.